We offer best-in-class strategy development tailored to your objectives to help realize the full value of your products and technologies.
We turn data – from every source – into robust, objective, and compelling insights that help you understand and prioritize payer evidence requirements, in support of your evidence generation planning.
We bring the tools, experience, and innovations you need to ensure your product is priced to match the value it brings to patients, payers, healthcare systems and wider society.
We work with you to gather the evidence, formulate the insights, and create the arguments you need to explain the value of your technology to payers and other key healthcare stakeholders.
We support your Access and Policy teams to define a strategic position and response to policies, trends, opportunities, and threats, and align your priorities with external health policy developments to bolster overall success.
We pride ourselves on fully understanding both your needs and those of your key stakeholders.
Examples of our services
Phase 1/1–2
Phase 2
Phase 3
In Line
All Phases
Define your Value Strategy
Gather payer input into TPP
Prioritize indications based on payer value
Understand the P&R and HTA landscape
Develop your market access strategy
Define and test outcomes- and finance-based agreement opportunities
Identify early access opportunities
Maximize brand value around loss-of exclusivity
Engage payers through digital solutions
Design and implement company wide value frameworks
Inform geographical expansion strategies
Optimize your evidence plan
Use payer preferences to inform the evidence generation plan
Inform the value-maximizing phase 3 design
Define the EU JCA evidence submission strategy
Identify gaps in evidence and plan for additional RWE
Leverage RWE to maintain access and pricing throughout the lifecycle
Build evidence generation frameworks
Price your asset right
Define the early pricing strategy
Assess the Economically Justifiable Price
Finalize launch prices and sequence
Inform indication expansion business cases
Conduct access and pricing due diligence
Strengthen pricing governance
Communicate the value
Co-create the aspirational payer value story
Communicate the burden and unmet needs of the disease
Develop and localize value materials
Implement negotiation frameworks
Demonstrate efficiencies with interactive budget impact models
Model value impact to healthcare systems
Navigate access policies
Tools we use
